/Abbvie%20Inc%20logo%20and%20meds-%20by%20Ascannio%20via%20Shutterstock.jpg)
North Chicago-based AbbVie Inc. (ABBV) is a research-based biopharmaceutical company that is engaged in the development and sale of pharmaceutical products. With a market cap of $342.9 billion, AbbVie operates as one of the world’s largest pharma companies. It is expected to release its Q3 earnings before the market opens on Wednesday, Oct. 30.
Ahead of the event, analysts expect AbbVie to report a profit of $2.94 per share, marginally down from $2.95 per share reported in the year-ago quarter. The company has exceeded Wall Street’s adjusted EPS projections in each of the past four quarters. Its adjusted EPS for the last reported quarter declined 8.9% year-over-year to $2.65 but surpassed the consensus estimates by 3.1%.